Sars-Cov-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage

Sars-Cov-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage Publisher Pubmed

Karami Fath M¹ ; Jahangiri A² ; Ganji M³ ; Sefid F⁴ ; Payandeh Z⁵ ; Hashemi ZS⁶ ; Pourzardosht N⁷ ; Hessami A⁸ ; Mardsoltani M⁹ ; Zakeri A¹⁰ ; Rahbar MR¹¹ ; Khalili S¹⁰

Show Affiliations

1. Department of Cellular and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran
2. Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
3. Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
4. Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
5. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
6. Advanced Therapy Medicinal Product (ATMP) Department, Breast Cancer Research Center, Motamed Cancer Institute, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran
7. Biochemistry Department, Guilan University of Medical Sciences, Rasht, Iran
8. School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
9. Department of Clinical Biochemistry, Faculty of Medical Sciences, Dezful University of Medical Sciences, Dezful, Iran
10. Department of Biology Sciences, Shahid Rajaee Teacher Training University, Tehran, Iran
11. Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Source: Frontiers in Immunology Published:2021

Abstract

Autoimmune diseases (ADs) could occur due to infectious diseases and vaccination programs. Since millions of people are expected to be infected with SARS-CoV-2 and vaccinated against it, autoimmune consequences seem inevitable. Therefore, we have investigated the whole proteome of the SARS-CoV-2 for its ability to trigger ADs. In this regard, the entire proteome of the SARS-CoV-2 was chopped into more than 48000 peptides. The produced peptides were searched against the entire human proteome to find shared peptides with similar experimentally confirmed T-cell and B-cell epitopes. The obtained peptides were checked for their ability to bind to HLA molecules. The possible population coverage was calculated for the most potent peptides. The obtained results indicated that the SARS-CoV-2 and human proteomes share 23 peptides originated from ORF1ab polyprotein, nonstructural protein NS7a, Surface glycoprotein, and Envelope protein of SARS-CoV-2. Among these peptides, 21 peptides had experimentally confirmed equivalent epitopes. Amongst, only nine peptides were predicted to bind to HLAs with known global allele frequency data, and three peptides were able to bind to experimentally confirmed HLAs of equivalent epitopes. Given the HLAs which have already been reported to be associated with ADs, the ESGLKTIL, RYPANSIV, NVAITRAK, and RRARSVAS were determined to be the most harmful peptides of the SARS-CoV-2 proteome. It would be expected that the COVID-19 pandemic and the vaccination against this pathogen could significantly increase the ADs incidences, especially in populations harboring HLA-B*08:01, HLA-A*024:02, HLA-A*11:01 and HLA-B*27:05. The Southeast Asia, East Asia, and Oceania are at higher risk of AD development. © Copyright © 2021 Karami Fath, Jahangiri, Ganji, Sefid, Payandeh, Hashemi, Pourzardosht, Hessami, Mard-Soltani, Zakeri, Rahbar and Khalili.

Related Docs

View other Related Docs

1. Covid-19: A Trigger of Autoimmune Diseases, Cell Biology International (2023)

2. Autoimmune Complications of Covid-19, Journal of Medical Virology (2022)

3. Partners in Crime: Autoantibodies Complicit in Covid-19 Pathogenesis, Reviews in Medical Virology (2023)

4. Multisystem Inflammatory Syndrome and Autoimmune Diseases Following Covid-19: Molecular Mechanisms and Therapeutic Opportunities, Frontiers in Molecular Biosciences (2022)

5. Liothyronine Could Block the Programmed Death-Ligand 1 (Pdl1) Activity: An E-Pharmacophore Modeling and Virtual Screening Study, Journal of Receptors and Signal Transduction (2022)

6. Pierce Into Structural Changes of Interactions Between Mutated Spike Glycoproteins and Ace2 to Evaluate Its Potential Biological and Therapeutic Consequences, International Journal of Peptide Research and Therapeutics (2022)

7. Sars-Cov-2 Nucleocapsid: Biological Functions and Implication for Disease Diagnosis and Vaccine Design, Reviews in Medical Virology (2023)

8. Autoimmune Encephalitis Associated With Covid-19: A Systematic Review, Multiple Sclerosis and Related Disorders (2022)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (3)

Fazel Shokri (2)

Style	Citing Format
MLA	Karami Fath M, et al.. "Sars-Cov-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage." Frontiers in Immunology, vol. 12, no. , 2021, pp. -.
APA	Karami Fath M, Jahangiri A, Ganji M, Sefid F, Payandeh Z, Hashemi ZS, Pourzardosht N, Hessami A, Mardsoltani M, Zakeri A, Rahbar MR, Khalili S (2021). Sars-Cov-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage. Frontiers in Immunology, 12(), -.
Chicago	Karami Fath M, Jahangiri A, Ganji M, Sefid F, Payandeh Z, Hashemi ZS, Pourzardosht N, et al.. "Sars-Cov-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage." Frontiers in Immunology 12, no. (2021): -.
Harvard	Karami Fath M et al. (2021) 'Sars-Cov-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage', Frontiers in Immunology, 12(), pp. -.
Vancouver	Karami Fath M, Jahangiri A, Ganji M, Sefid F, Payandeh Z, Hashemi ZS, et al.. Sars-Cov-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage. Frontiers in Immunology. 2021;12():-.
BibTex	@article{ author = {Karami Fath M and Jahangiri A and Ganji M and Sefid F and Payandeh Z and Hashemi ZS and Pourzardosht N and Hessami A and Mardsoltani M and Zakeri A and Rahbar MR and Khalili S}, title = {Sars-Cov-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage}, journal = {Frontiers in Immunology}, volume = {12}, number = {}, pages = {-}, year = {2021} }
RIS	TY - JOUR AU - Karami Fath M AU - Jahangiri A AU - Ganji M AU - Sefid F AU - Payandeh Z AU - Hashemi ZS AU - Pourzardosht N AU - Hessami A AU - Mardsoltani M AU - Zakeri A AU - Rahbar MR AU - Khalili S TI - Sars-Cov-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage JO - Frontiers in Immunology VL - 12 IS - SP - EP - PY - 2021 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract